Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    CMS Enforcement Arsenal Expands To Share OIG’s Exclusion Authority

    The Centers for Medicare & Medicaid Services has been granted unprecedented authority to exclude individuals and entities from federal healthcare programs, a power previously held exclusively by the HHS Office of Inspector General. This expansion raises critical questions about how the two agencies will coordinate exclusion decisions, particularly in False Claims Act settlements, and what criteria CMS will apply when wielding this significant enforcement tool. Healthcare providers and entities now face unce
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Schulte
    McDermott Will & Schulte
  • Article

    The Key Things Health Care Providers Need To Know About COVID-19 – Ensuring Compliance With Agency Measures

    According to the CDC, on January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization ("WHO") ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Womble Bond Dickinson
    Womble Bond Dickinson
  • Article

    CMS Launches New Medicare Part D Payment Modernization Model

    The Centers for Medicare & Medicaid Services (CMS) has announced a new Medicare Part D Payment Modernization Model (Part D Model), which will be tested by the CMS Center for Medicare and Medicaid Innovation.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Issues Proposed Guidance On Inflation Rebates Under Medicare Part D

    On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) released initial program guidance on the inflation rebate provisions of the Inflation Reduction Act of 2022 (IRA).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    CMS Vaccine Mandate And Home Care Providers – Investor Takeaways

    The COVID-19 vaccine mandate implemented by the Centers for Medicare and Medicaid Services (CMS) has affected investor interest in non-acute care providers and suppliers, including home care providers.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    CMS’ 2012 OPPS Final Rule Revises Physician Supervision Requirements

    The U.S. Centers for Medicare & Medicaid Services (CMS) further revised its physician supervision policy by finalizing the federal Advisory Panel on Ambulatory Payment Classification Groups as the independent review body to evaluate and recommend physician supervision levels to CMS, and by defining personal supervision and general supervision for all hospital outpatient therapeutic services.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    CMS Proposes New Mandatory Value-Based Payment Initiative: The Transforming Episode Accountability Model

    The Centers for Medicare & Medicaid Services (CMS) recently proposed the Transforming Episode Accountability Model (TEAM) – a new, mandatory...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS Releases CY 2025 Medicare Physician Fee Schedule Proposed Rule

    The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2025 Revisions to Payment Policies Under the Physician Fee Schedule (MPFS) and Other Revisions to Medicare
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    2014 Medicare ACO Results Released: CMS Asserts Success But Few ACOs Receive Payments

    The Centers for Medicare and Medicaid Services (CMS) released, on August 25, 2015, the quality and financial performance results for Medicare Accountable Care Organizations for 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    CMS' Web Portal: Final Rule 21 CFR § 411.39 Promises Quick and Efficient Conditional Payment Resolution for Those Able to Abide by Its Strict Guidelines

    The Centers for Medicare & Medicaid Services (CMS) has published its long-awaited final rule entitled "Medicare Program: Obtaining Final Medicare Secondary Payer Conditional Payment Amounts via Web Portal."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    CMS Finalizes Medicare Part B Reimbursement Cut For 340B – What Does It Mean?

    On November 1, 2017, CMS announced that it is in fact cutting Medicare Part B reimbursement for 340B drugs to the tune of $1.6 billion.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    CMS Proposes Important Enhancements To The New Technology Add-on Payment Program In The FY 2025 IPPS Proposed Rulemaking

    On April 10, 2024, CMS published the fiscal year (FY) 2025 Medicare Hospital Inpatient Prospective Payment Systems (IPPS) Proposed Rule, which contains several key proposals...
    United StatesTechnology
    Foley Hoag LLP
    Foley Hoag LLP
  • Article

    CMS's Draft 2018 Call Letter: Minor Updates, But Largely A Continuation Of Current Policies

    This blog is to highlight some key provisions and changes as MA and Part D plans prepare and finalize comments.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    CMS Proposes FY 2017 Update For Medicare IPPS, LTCH PPS Rates And Policies

    CMS has published its proposed rule to update the Medicare acute hospital inpatient prospective payment system and long-term care hospital prospective payment system for fiscal year 2017.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    FDA & CMS Launch Pilot Program For Parallel Review Of Medical Devices

    People are sometimes surprised to learn that the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) do not coordinate their decisions on whether a medical device can be marketed and whether the government’s insurance programs will pay for it.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Barnes & Thornburg LLP
    Barnes & Thornburg LLP
  • Article

    Upcoming CMS Marketing Rule Changes

    As our readers know, the Centers for Medicare & Medicaid Services ("CMS") prohibits certain marketing communications, materials, and activities.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Klein Moynihan Turco LLP
    Klein Moynihan Turco LLP
  • Article

    CMS Releases CY 24 Medicare Physician Fee Schedule Proposed Rule

    The Centers for Medicare & Medicaid Services (CMS) has released the calendar year (CY) 2024 Revisions to Payment Policies Under the Physician Fee Schedule (MPFS) and Other Revisions to Medicare Part B...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    PAMA Final Rule

    On June 17, 2016 the Centers of Medicare & Medicaid Services (CMS) issued the long awaited Medicare Clinical Diagnostic Laboratory Tests Payment System Final Rule.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley Hoag LLP
    Foley Hoag LLP
  • Article

    Temporary COVID-19 Medicare/Medicaid Changes: Updates In The Second Interim Final Rule

    On April 30, 2020, the Centers for Medicare & Medicaid Services ("CMS") issued its Second Interim Final Rule in response to the COVID-19 pandemic, which includes additional regulatory waivers...
    United StatesCoronavirus (COVID-19)
    Proskauer Rose LLP
    Proskauer Rose LLP
  • Article

    CMS Proposes To Both Ease And Tighten Physician Supervision Requirements For Hospital Outpatient Services

    On July 1, 2009, CMS placed on display its proposed changes to its Hospital Outpatient Prospective Payment System rule. Included among those changes are proposals to alter CMS's physician supervision requirements pertaining to hospital outpatient services, requirements that have been in flux since last year.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Ober Kaler
    Ober Kaler

Showing 601–620 of 15707 results

PreviousNext
Legal Intelligence Newsletters